The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a major threat to public health. Despite the approval of several biologic and small molecule therapeutics, there is an urgent need for new small molecule antivirals with distinct …